Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Mycophenolate mofetil]

D Abramowicz1, N Broeders, M Wissing

  • 1Service de Néphrologie, Hôpital Erasme, U.L.B.

Revue Medicale De Bruxelles
|August 11, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Cushing Reflex: Oliguria as a Reflection of an Elevated Intracranial Pressure.

Case reports in nephrology·2017
Same author

Operational tolerance in kidney transplantation and associated biomarkers.

Clinical and experimental immunology·2017
Same author

Single-Center Case Series of Donor-Related Malignancies: Rare Cases With Tremendous Impact.

Transplantation proceedings·2016
Same author

Genome-Wide Association Study of Acute Renal Graft Rejection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

Traitement Des Infections Bronchopulmonaires Aigues Par Le Laurylsulfate De Tetracycline Intra-Musculaire.

Acta clinica Belgica·2016
Same author

Old Habits Die Hard: Screening for and Treating Asymptomatic Bacteriuria After Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same journal

[Breast cancer screening : a tool for informed decision making].

Revue medicale de Bruxelles·2018
Same journal

[Breast cancer screening : present situation and prospects].

Revue medicale de Bruxelles·2018
Same journal

[Guidelines in medical imaging : objectives, limits and radiation protection].

Revue medicale de Bruxelles·2018
Same journal

[How to avoid overmedicalization of the elderly patient ?]

Revue medicale de Bruxelles·2018
Same journal

[Ethical, pedagogical, socio-political and anthropological implications of quaternary prevention].

Revue medicale de Bruxelles·2018
Same journal

[New strategies in specific care for benign prostatic hypertrophy in older men].

Revue medicale de Bruxelles·2018
See all related articles

Mycophenolate Mofetil (MMF) is a novel immunosuppressant for renal transplants, reducing acute rejection episodes. While causing diarrhea and leucopenia, it avoids cyclosporine

Area of Science:

  • Immunology
  • Nephrology
  • Transplantation Medicine

Background:

  • Mycophenolate Mofetil (MMF) is a selective immunosuppressive agent targeting T and B lymphocyte proliferation.
  • Current immunosuppressive regimens in renal transplantation involve agents with significant toxicities, such as cyclosporine and corticosteroids.

Purpose of the Study:

  • To evaluate the efficacy of Mycophenolate Mofetil (MMF) in reducing acute rejection episodes in renal transplant recipients.
  • To assess the safety profile of MMF, including its main toxicities and comparison to existing immunosuppressants.
  • To explore the potential for MMF to enable the discontinuation of cyclosporine or corticosteroid therapy.

Main Methods:

  • Clinical trials involving renal transplant recipients.
  • Assessment of acute rejection episodes within the first year post-transplantation.

Related Experiment Videos

  • Monitoring for adverse events, specifically diarrhea and leucopenia.
  • Comparative analysis of MMF's toxicity profile against cyclosporine and corticosteroids.

    • Main Results:

    • MMF significantly reduced the incidence of acute rejection episodes in the first year after renal transplantation.
    • The primary toxicities associated with MMF were diarrhea and leucopenia.
    • MMF demonstrated a lack of nephrotoxicity, unlike cyclosporine, and fewer adverse effects compared to corticosteroids.

    Conclusions:

    • Mycophenolate Mofetil (MMF) is an effective immunosuppressant in renal transplantation, reducing acute rejection.
    • MMF offers an improved safety profile compared to cyclosporine and corticosteroids, with manageable toxicities.
    • Ongoing trials aim to determine if MMF can replace or reduce the need for other immunosuppressants, potentially advancing transplantation outcomes.